Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AARSD1,Alanyl-tRNA editing protein Aarsd1,25620,34,1.65 [1.01-2.71],0.0453052455079644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ABCA2,ATP-binding cassette sub-family A member 2,21746,28,2.37 [1.25-4.49],0.0083096483499724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",22028,29,1.41 [1.06-1.89],0.0188589014094741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACAN,Aggrecan core protein,25522,35,4.85 [1.70-13.81],0.0031360404489558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACE,Angiotensin-converting enzyme,22460,29,5.69 [2.47-13.14],4.5839534922963176e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACE2,Angiotensin-converting enzyme 2,25270,35,1.80 [1.15-2.81],0.0101813893982286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACHE,Acetylcholinesterase,21977,28,3.18 [1.73-5.85],0.0002010233741957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,25858,36,3.30 [2.11-5.17],1.940820224701104e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACRV1,Acrosomal protein SP-10,21822,29,2.18 [1.10-4.30],0.0246931682705456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACTA2,"Actin, aortic smooth muscle",25270,35,2.91 [2.25-3.76],4.166962228578637e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACTN2,Alpha-actinin-2,21746,28,1.92 [1.25-2.94],0.0027930302439902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,21746,28,2.19 [1.32-3.64],0.0023812549546928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACYP1,Acylphosphatase-1,21886,28,1.71 [1.02-2.86],0.0402578919067637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADA,Adenosine deaminase,26012,34,4.62 [2.76-7.73],5.761500602463765e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADA2,Adenosine deaminase 2,25576,36,7.33 [4.62-11.63],2.4966969054791882e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,21822,29,2.41 [1.73-3.35],2.1588589853978933e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,26012,34,8.69 [3.12-24.17],3.438333341892608e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,25923,35,5.87 [2.69-12.80],8.491670442542594e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,22348,29,6.46 [3.80-10.98],5.417390241953518e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,21822,29,2.40 [1.44-4.00],0.0007666966094061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,25620,34,3.26 [1.69-6.31],0.0004395072411757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,25270,35,2.15 [1.56-2.98],3.680072708267816e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,21822,29,2.36 [1.29-4.31],0.0053033301210732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,25832,34,2.78 [1.41-5.47],0.003071741464915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,22447,28,6.36 [2.88-14.05],4.780645762987549e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,21977,28,8.52 [4.18-17.37],3.7047989713648526e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRE1,Adhesion G protein-coupled receptor E1,22348,29,2.63 [1.64-4.21],6.366649640675889e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,25928,36,6.55 [3.79-11.31],1.59235105542807e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,25620,34,2.47 [1.91-3.20],7.396077725804541e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRG2,Adhesion G-protein coupled receptor G2,25743,35,0.16 [0.06-0.44],0.0004965288930279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADM,Pro-adrenomedullin,25954,34,6.46 [2.02-20.61],0.0016242449697621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AFP,Alpha-fetoprotein,25497,33,0.52 [0.32-0.84],0.0080568060038178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AGR2,Anterior gradient protein 2 homolog,24908,32,2.18 [1.75-2.72],4.694944952345359e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AGRN,Agrin,25875,34,5.76 [3.34-9.93],2.9390891686866004e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AHNAK,Neuroblast differentiation-associated protein AHNAK,21875,29,3.40 [1.90-6.11],4.0522903757589886e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AHNAK2,Protein AHNAK2,21875,29,5.15 [2.82-9.42],1.0142301949397517e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AHSP,Alpha-hemoglobin-stabilizing protein,25702,35,1.39 [1.01-1.93],0.0446227036121952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AK1,Adenylate kinase isoenzyme 1,25743,35,1.59 [1.05-2.40],0.0276157522598899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AKAP12,A-kinase anchor protein 12,21977,28,2.55 [1.38-4.71],0.0028270496085917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AKR1B10,Aldo-keto reductase family 1 member B10,21825,29,1.69 [1.17-2.45],0.0056373648993539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",25669,33,1.46 [1.10-1.95],0.0094193442532817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AMFR,E3 ubiquitin-protein ligase AMFR,25133,33,1.53 [1.10-2.13],0.0105750334952834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AMIGO2,Amphoterin-induced protein 2,25620,34,5.94 [1.65-21.42],0.0064243094446465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,21020,29,0.10 [0.05-0.23],9.645906885326353e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AMY2A,Pancreatic alpha-amylase,24741,35,0.29 [0.16-0.54],7.52015468963361e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AMY2B,Alpha-amylase 2B,24003,34,0.25 [0.13-0.47],1.2388953789729226e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANGPT2,Angiopoietin-2,25954,34,4.28 [2.34-7.85],2.490869782588506e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,25400,34,6.06 [2.28-16.14],0.0003115859730998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,25832,34,5.34 [2.81-10.13],2.997998928912411e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,25954,34,2.77 [1.55-4.94],0.0005614204625271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANPEP,Aminopeptidase N,25784,36,4.54 [2.29-9.02],1.5449305123638687e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANXA1,Annexin A1,21837,28,1.83 [1.14-2.94],0.0122831344349358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANXA10,Annexin A10,25133,33,1.65 [1.26-2.16],0.000272455461884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANXA5,Annexin A5,25058,33,3.52 [2.01-6.14],9.942113264763776e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AOC1,Amiloride-sensitive amine oxidase [copper-containing],25239,34,1.67 [1.30-2.15],6.170708006130833e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APCS,Serum amyloid P-component,22290,28,0.38 [0.16-0.92],0.0321461018730741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOA2,Apolipoprotein A-II,22460,29,2.67 [1.43-4.95],0.0019209767597955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOA4,Apolipoprotein A-IV,22491,28,2.92 [1.98-4.31],7.095470698923413e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOE,Apolipoprotein E,22491,28,0.39 [0.19-0.80],0.0105663945497004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOH,Beta-2-glycoprotein 1,25740,35,2.25 [1.20-4.24],0.011967255090808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOL1,Apolipoprotein L1,22460,29,0.27 [0.15-0.48],5.300800758266232e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOM,Apolipoprotein M,25784,36,0.21 [0.08-0.56],0.0019224320603432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APRT,Adenine phosphoribosyltransferase,25533,33,2.11 [1.06-4.18],0.0327107298220922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AREG,Amphiregulin,25620,34,2.79 [1.94-4.03],3.6971005252243856e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARHGAP5,Rho GTPase-activating protein 5,21644,29,1.54 [1.15-2.07],0.0038225866667249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARHGEF5,Rho guanine nucleotide exchange factor 5,21739,29,1.70 [1.25-2.31],0.0006373676641888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,21746,28,0.34 [0.13-0.89],0.0284089643120766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,25571,33,9.24 [4.48-19.09],1.853508643952773e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,22460,29,8.45 [3.31-21.59],8.111850076038193e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATP6AP2,Renin receptor,25147,34,1.84 [1.23-2.74],0.0028954339303056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,22348,29,2.42 [1.74-3.35],1.334370557498583e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AXL,Tyrosine-protein kinase receptor UFO,25829,36,7.45 [3.84-14.46],2.8712142693542555e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",B2M,Beta-2-microglobulin,22491,28,2.05 [1.52-2.76],2.318896622550258e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",21875,29,9.85 [4.44-21.85],1.8850729921310084e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",B4GAT1,"Beta-1,4-glucuronyltransferase 1",25740,35,3.69 [1.17-11.69],0.0263574802203687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,25147,34,4.90 [2.99-8.05],3.3181240998891847e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BCAM,Basal cell adhesion molecule,25740,35,6.92 [3.48-13.72],3.204159004642001e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",25705,33,2.76 [1.22-6.26],0.0148012985682244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BCL2L15,Bcl-2-like protein 15,21822,29,1.82 [1.27-2.60],0.0010033108149983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BLMH,Bleomycin hydrolase,26057,36,2.28 [1.24-4.20],0.008185419909846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BLVRB,Flavin reductase,25740,35,1.48 [1.01-2.16],0.0450028383593621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BMP10,Bone morphogenetic protein 10,21977,28,6.09 [1.68-22.07],0.0059626591367489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BMP4,Bone morphogenetic protein 4,25532,33,2.07 [1.17-3.66],0.0127902196076108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BMPER,BMP-binding endothelial regulator protein,21977,28,7.11 [3.60-14.04],1.6489452359968232e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BOLA1,BolA-like protein 1,21739,29,1.74 [1.15-2.63],0.0081380666174367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BOLA2_BOLA2B,BolA-like protein 2,21875,29,2.21 [1.16-4.21],0.0153450306981562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BRK1,Protein BRICK1,25133,33,2.48 [1.43-4.32],0.0013141625544842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BRME1,Break repair meiotic recombinase recruitment factor 1,21739,29,1.51 [1.07-2.14],0.0193827817365833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,25967,35,3.55 [1.16-10.88],0.0269020377462332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BST2,Bone marrow stromal antigen 2,25967,35,1.63 [1.12-2.38],0.0110871192774494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BTLA,B- and T-lymphocyte attenuator,21644,29,1.33 [1.07-1.67],0.0112638808733251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,25705,33,2.58 [1.65-4.03],3.4640374565614284e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,25829,36,3.18 [2.06-4.92],1.7189394060276456e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,21977,28,3.61 [1.49-8.77],0.0045555799785742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,22416,29,2.84 [1.68-4.81],0.000101769382122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,21931,28,7.72 [3.54-16.80],2.6226688372376054e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C9orf40,Uncharacterized protein C9orf40,22348,29,1.49 [1.01-2.19],0.0454173887177828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA12,Carbonic anhydrase 12,25620,34,6.76 [4.60-9.91],1.5542917762872711e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA14,Carbonic anhydrase 14,25954,34,5.40 [2.83-10.32],3.309756427199332e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA2,Carbonic anhydrase 2,25654,35,1.49 [1.02-2.17],0.0412590088282614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA3,Carbonic anhydrase 3,26009,36,2.30 [1.59-3.33],1.0462690771133008e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",25270,35,1.35 [1.02-1.79],0.0331688781281956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA9,Carbonic anhydrase 9,25954,34,3.61 [2.40-5.44],8.017407670132316e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CALB1,Calbindin,25620,34,3.48 [2.09-5.77],1.4235918262223665e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CALB2,Calretinin,25133,33,1.77 [1.25-2.50],0.0013815837559549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CALCA,Calcitonin,25523,33,1.84 [1.39-2.44],2.294820980220022e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CALCB,Calcitonin gene-related peptide 2,22407,29,2.28 [1.59-3.26],7.743790690431883e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CAPG,Macrophage-capping protein,25540,34,1.81 [1.18-2.78],0.0061258651238101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CAPS,Calcyphosin,22407,29,1.34 [1.08-1.66],0.0077102455670356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CARHSP1,Calcium-regulated heat-stable protein 1,25133,33,1.67 [1.01-2.74],0.0436230941727975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CAT,Catalase,22119,29,1.92 [1.13-3.26],0.0155668234568299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CBLIF,Cobalamin binding intrinsic factor,25699,35,1.60 [1.11-2.31],0.0115827078380608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,25571,33,1.52 [1.05-2.21],0.0262697759391004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,25743,35,3.35 [2.06-5.45],1.1506271054968797e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,21875,29,2.02 [1.31-3.13],0.0015589614931043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL11,Eotaxin,26012,34,2.98 [1.36-6.51],0.006393739632859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL14,C-C motif chemokine 14,25654,36,2.18 [1.33-3.55],0.0018655660767634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL15,C-C motif chemokine 15,26057,36,4.45 [2.84-6.98],8.3372266433791e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL16,C-C motif chemokine 16,26057,36,2.37 [1.37-4.12],0.0021732032656463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL18,C-C motif chemokine 18,25358,36,1.40 [1.02-1.91],0.0370444963620281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL2,C-C motif chemokine 2,25532,33,1.80 [1.10-2.95],0.0193745680954652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL20,C-C motif chemokine 20,26012,34,1.48 [1.18-1.85],0.0006389784342658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL21,C-C motif chemokine 21,25875,34,2.05 [1.49-2.80],8.016552393206966e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL25,C-C motif chemokine 25,26012,34,4.04 [2.38-6.88],2.564789375636824e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL27,C-C motif chemokine 27,25743,35,1.80 [1.10-2.93],0.0187230110999833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL8,C-C motif chemokine 8,25919,34,1.74 [1.05-2.87],0.0311465464223615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCN3,CCN family member 3,26025,36,7.80 [5.19-11.72],4.727806042006241e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCN4,CCN family member 4,25954,34,5.06 [3.02-8.48],7.01611760410919e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCN5,CCN family member 5,25740,35,9.40 [5.60-15.78],2.281835939076156e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD109,CD109 antigen,25740,35,7.90 [3.54-17.64],4.659817572632227e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD14,Monocyte differentiation antigen CD14,25174,36,5.64 [3.48-9.14],2.3326325244783537e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD160,CD160 antigen,26012,34,4.56 [2.91-7.13],3.140785731116153e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,25829,36,3.13 [1.79-5.49],6.415838754169455e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD164,Sialomucin core protein 24,25740,35,2.41 [1.71-3.41],6.278463009580718e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD177,CD177 antigen,25701,35,1.43 [1.09-1.89],0.0097539458194899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD2,T-cell surface antigen CD2,21746,28,1.74 [1.09-2.78],0.0197744487981633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD200,OX-2 membrane glycoprotein,25705,33,9.07 [4.18-19.71],2.5300491294411483e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD200R1,Cell surface glycoprotein CD200 receptor 1,25622,32,3.33 [1.58-6.99],0.0014974232811018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD207,C-type lectin domain family 4 member K,25186,34,4.64 [2.60-8.26],1.884560359660092e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD22,B-cell receptor CD22,26012,34,1.91 [1.00-3.66],0.0498948221845197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD244,Natural killer cell receptor 2B4,26012,34,4.88 [1.89-12.63],0.0010743672480919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD27,CD27 antigen,25832,34,8.01 [5.26-12.22],3.7831419989084514e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD274,Programmed cell death 1 ligand 1,25571,33,3.91 [2.42-6.31],2.2420894571434786e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,25147,34,3.11 [1.98-4.89],9.21722457850787e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD2AP,CD2-associated protein,25743,35,1.71 [1.13-2.60],0.0117708526457859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300C,CMRF35-like molecule 6,25967,35,8.16 [4.62-14.43],5.057621797698937e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300E,CMRF35-like molecule 2,25860,34,5.69 [3.62-8.93],4.2974596472192736e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300LF,CMRF35-like molecule 1,25954,34,2.07 [1.19-3.60],0.0095291299918989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD302,CD302 antigen,25620,34,7.63 [4.39-13.27],5.592299843511728e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,25620,34,8.07 [4.45-14.61],5.537427361725581e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD4,T-cell surface glycoprotein CD4,25665,32,1.88 [1.13-3.15],0.0154122585970865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,25748,34,2.47 [1.51-4.02],0.0002979977905705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD46,Membrane cofactor protein,25566,36,5.18 [3.33-8.06],3.081122621266634e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD48,CD48 antigen,25832,34,9.00 [4.30-18.82],5.2767588341901134e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD5,T-cell surface glycoprotein CD5,25919,34,2.92 [1.77-4.81],2.5829069605488826e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD55,Complement decay-accelerating factor,24838,36,5.10 [3.24-8.03],1.858789506457781e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD5L,CD5 antigen-like,22357,28,2.61 [1.35-5.05],0.0042776783612121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD7,T-cell antigen CD7,21778,29,2.71 [1.73-4.23],1.2939694106163877e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD70,CD70 antigen,25705,33,3.15 [1.74-5.71],0.0001586723878735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD72,B-cell differentiation antigen CD72,21977,28,3.47 [1.95-6.17],2.3315546237671204e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,25967,35,8.96 [5.22-15.39],1.9414202318881838e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,26012,34,3.89 [2.79-5.42],9.446254528008757e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD80,T-lymphocyte activation antigen CD80,22457,29,4.85 [2.57-9.16],1.1671516956720874e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD83,CD83 antigen,25705,33,5.95 [3.31-10.70],2.618402578454315e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD93,Complement component C1q receptor,24753,35,9.80 [5.47-17.56],1.7796484881166226e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDA,Cytidine deaminase,22409,29,1.91 [1.08-3.38],0.0264619150726199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDCP1,CUB domain-containing protein 1,25571,33,1.98 [1.17-3.36],0.0110290105537269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH1,Cadherin-1,24883,36,3.31 [2.46-4.47],4.28398266445085e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH15,Cadherin-15,25919,35,2.61 [1.85-3.69],4.9294160365521626e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH17,Cadherin-17,25743,35,2.45 [1.74-3.45],2.548904168401857e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH2,Cadherin-2,25743,35,4.79 [2.15-10.67],0.0001241623901958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH3,Cadherin-3,25967,35,4.88 [2.96-8.04],5.003995795629073e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH5,Cadherin-5,26057,36,4.22 [1.96-9.10],0.0002324755106351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH6,Cadherin-6,25743,35,5.93 [3.16-11.13],3.052188945678743e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDHR5,Cadherin-related family member 5,25743,35,0.49 [0.25-0.95],0.0352465370291599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDK1,Cyclin-dependent kinase 1,21644,29,2.56 [1.17-5.58],0.0181441203534251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDNF,Cerebral dopamine neurotrophic factor,25620,34,2.78 [1.74-4.42],1.6667154723326163e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDSN,Corneodesmosin,25929,34,3.09 [1.63-5.85],0.0005269055447763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,22348,29,2.90 [1.54-5.48],0.0010318338304037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,22028,29,1.81 [1.19-2.75],0.0055108800964876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,25705,33,1.53 [1.11-2.12],0.0097219179028491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,24813,33,1.62 [1.12-2.34],0.009978232656874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,22447,28,2.13 [1.02-4.43],0.0440233610496134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,25270,35,2.29 [1.47-3.58],0.0002524622782426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,22447,28,0.21 [0.14-0.31],7.429221955251188e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CELA3A,Chymotrypsin-like elastase family member 3A,26011,36,0.28 [0.19-0.43],1.1180849558286275e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,21977,28,2.68 [1.02-7.05],0.0451266081915747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEP164,Centrosomal protein of 164 kDa,25239,34,1.37 [1.02-1.83],0.0342026696295215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CFC1,Cryptic protein,25147,34,0.35 [0.16-0.77],0.0094316468420405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CFD,Complement factor D,22491,28,6.80 [2.67-17.35],5.996365686327228e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CFI,Complement factor I,22491,28,0.16 [0.03-0.90],0.0373025714148646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CFP,Properdin,22491,28,0.10 [0.02-0.53],0.0067545077538671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,25743,35,9.84 [5.88-16.45],2.8191203198512057e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,25147,34,1.51 [1.02-2.24],0.0382685678130678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",22407,29,4.43 [2.97-6.62],3.182237336884343e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHCHD6,MICOS complex subunit MIC25,22325,29,2.49 [1.46-4.24],0.0008142836439906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHGA,Chromogranin-A,22447,28,1.81 [1.41-2.33],4.009841798076605e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHGB,Secretogranin-1,25870,35,4.37 [2.74-6.96],5.972277318437487e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHI3L1,Chitinase-3-like protein 1,25160,36,2.07 [1.59-2.70],6.294596569085662e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHIT1,Chitotriosidase-1,25847,36,1.38 [1.01-1.90],0.0455097585881658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHL1,Neural cell adhesion molecule L1-like protein,25790,35,4.00 [1.96-8.16],0.0001387970757152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CIAPIN1,Anamorsin,25832,34,1.65 [1.04-2.61],0.0330318740239351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CILP,Cartilage intermediate layer protein 1,22447,28,3.88 [2.33-6.46],1.8821664023547258e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,25884,34,9.41 [5.54-15.98],1.1341543272224678e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CKB,Creatine kinase B-type,22447,28,4.47 [2.56-7.81],1.4019781665558893e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLC,Galectin-10,25705,35,2.06 [1.52-2.81],4.01072748436622e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,25571,33,4.75 [2.16-10.47],0.0001074400766113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,25705,33,1.83 [1.16-2.88],0.0096257743042065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,25659,35,7.42 [3.94-13.94],4.947348935587624e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,25147,34,1.96 [1.15-3.35],0.0140165685060428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,26012,34,3.09 [1.65-5.82],0.0004579406711642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLGN,Calmegin,21825,29,2.16 [1.27-3.65],0.0042516886608157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLIC5,Chloride intracellular channel protein 5,21825,29,2.25 [1.34-3.80],0.002256401821416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLNS1A,Methylosome subunit pICln,21825,29,2.89 [1.50-5.60],0.0016044676735578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLSTN2,Calsyntenin-2,26012,34,2.61 [1.52-4.48],0.0005147618353596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLTA,Clathrin light chain A,25270,35,1.71 [1.09-2.69],0.0198519049110348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,25829,36,0.48 [0.30-0.78],0.0031371408527136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNTF,Ciliary neurotrophic factor,21739,29,2.24 [1.09-4.62],0.0289763089099049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNTN2,Contactin-2,25954,34,3.79 [2.05-7.00],2.2022167466267924e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNTNAP2,Contactin-associated protein-like 2,25705,33,3.49 [2.01-6.05],9.045110808250014e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COCH,Cochlin,22457,29,1.99 [1.04-3.82],0.0374918406402996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL15A1,Collagen alpha-1(XV) chain,22447,28,5.99 [2.29-15.69],0.0002664955454659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL1A1,Collagen alpha-1(I) chain,26057,36,3.04 [1.02-9.03],0.0453391953343514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL2A1,Collagen alpha-1(II) chain,21875,29,1.61 [1.08-2.40],0.0196677940398798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,25743,35,5.94 [3.57-9.89],6.548000869770175e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL5A1,Collagen alpha-1(V) chain,21977,28,2.23 [1.11-4.48],0.0244670325870509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CORO6,Coronin-6,21739,29,1.81 [1.00-3.27],0.0494349432062088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPA1,Carboxypeptidase A1,26057,36,0.30 [0.20-0.44],1.96307786674645e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPB1,Carboxypeptidase B,26057,36,0.25 [0.16-0.41],4.564252571815774e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPM,Carboxypeptidase M,25846,35,3.23 [1.62-6.45],0.0008596694262859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPPED1,Serine/threonine-protein phosphatase CPPED1,25967,35,1.61 [1.06-2.45],0.0257762669040133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPTP,Ceramide-1-phosphate transfer protein,21746,28,2.09 [1.30-3.35],0.0023722166179455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPVL,Probable serine carboxypeptidase CPVL,25919,34,2.76 [1.26-6.03],0.01112099907078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,22457,29,4.22 [2.24-7.97],8.550082765044475e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CR1,Complement receptor type 1,22369,29,2.65 [1.67-4.21],3.571855640324682e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CREG1,Protein CREG1,25411,33,0.33 [0.14-0.80],0.014109663886892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,21977,28,6.68 [2.73-16.32],3.0873225146342285e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,25832,34,2.02 [1.20-3.38],0.0079465758672786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,25753,33,3.90 [1.29-11.76],0.0158376198668463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,25875,34,6.67 [2.23-20.00],0.0007035958673266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRIP2,Cysteine-rich protein 2,25571,33,2.92 [1.89-4.50],1.251793140477834e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,25954,34,0.59 [0.39-0.90],0.0143815462754715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRISP3,Cysteine-rich secretory protein 3,22253,28,0.30 [0.10-0.94],0.0389725008266114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRLF1,Cytokine receptor-like factor 1,25875,34,3.62 [1.25-10.49],0.0178489328634096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRTAC1,Cartilage acidic protein 1,26057,36,0.25 [0.11-0.57],0.0009940339511563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRTAM,Cytotoxic and regulatory T-cell molecule,25571,33,3.50 [2.10-5.84],1.671200548639262e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRYBB2,Beta-crystallin B2,22407,29,1.81 [1.53-2.15],1.1794516106946773e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSF1R,Macrophage colony-stimulating factor 1 receptor,22460,29,3.34 [1.79-6.23],0.00015529084007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSNK2A1,Casein kinase II subunit alpha,22416,29,2.13 [1.04-4.35],0.0380014909903722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,22447,28,8.35 [3.19-21.88],1.5809195858129327e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSRP3,Cysteine and glycine-rich protein 3,21746,28,1.41 [1.10-1.82],0.0074075407074938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CST5,Cystatin-D,25310,33,2.00 [1.23-3.25],0.0054071964895991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CST6,Cystatin-M,25058,35,2.48 [1.37-4.46],0.002524418875586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSTB,Cystatin-B,25381,36,4.92 [3.24-7.49],9.541024009394969e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,22447,28,9.61 [5.22-17.68],3.633723953772969e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTRB1,Chymotrypsinogen B,25740,35,0.25 [0.16-0.40],1.6775079966626452e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTRC,Chymotrypsin-C,25755,33,0.26 [0.18-0.38],6.962643648727385e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,22407,29,0.23 [0.16-0.34],2.3802472480616832e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSD,Cathepsin D,24031,36,2.49 [1.72-3.62],1.4286293242466186e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSE,Cathepsin E,21977,28,2.36 [1.22-4.55],0.0105209839900866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSH,Pro-cathepsin H,25193,35,1.66 [1.13-2.43],0.0091696207462753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSO,Cathepsin O,26012,34,5.41 [2.69-10.91],2.309935036239194e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSV,Cathepsin L2,25879,34,0.34 [0.17-0.71],0.0039082223296899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CX3CL1,Fractalkine,25571,33,5.49 [3.21-9.39],5.131573009845182e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,25705,33,2.28 [1.51-3.42],7.592547261626733e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXCL1,Growth-regulated alpha protein,25705,34,1.31 [1.01-1.69],0.0382508477449986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXCL13,C-X-C motif chemokine 13,25967,35,1.50 [1.18-1.90],0.0008433132470733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXCL9,C-X-C motif chemokine 9,25875,34,1.75 [1.28-2.40],0.0005186936201895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DAG1,Dystroglycan,25875,34,1.90 [1.02-3.56],0.044171179220459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DBI,Acyl-CoA-binding protein,25621,35,1.53 [1.06-2.22],0.0234106008047685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",25620,34,2.15 [1.32-3.50],0.0022111833872495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,25967,35,7.64 [4.02-14.49],4.91384705342291e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DDT,D-dopachrome decarboxylase,22447,28,2.36 [1.35-4.10],0.0024264262889692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,25222,35,2.04 [1.46-2.84],2.6992451325471413e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DEFB103A_DEFB103B,Beta-defensin 103,21647,28,1.62 [1.03-2.56],0.0365451870250662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,22407,29,1.71 [1.02-2.84],0.0400589128835689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DIPK2B,Divergent protein kinase domain 2B,21977,28,4.56 [1.86-11.19],0.0009114647242542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DKK3,Dickkopf-related protein 3,26057,36,5.35 [2.25-12.69],0.0001430187660142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DKK4,Dickkopf-related protein 4,25531,33,3.35 [2.45-4.58],4.0431835165334885e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DLK1,Protein delta homolog 1,26057,36,3.53 [2.11-5.92],1.644264497271544e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DLL4,Delta-like protein 4,21875,29,1.25 [1.02-1.52],0.0289053444523745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DMD,Dystrophin,21875,29,1.72 [1.17-2.53],0.0058355644965491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,21875,29,0.63 [0.42-0.93],0.0205192433728322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DNAJA4,DnaJ homolog subfamily A member 4,22407,29,1.70 [1.11-2.62],0.0156924201281233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DNAJB2,DnaJ homolog subfamily B member 2,21977,28,2.05 [1.16-3.61],0.0134614310125465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DNM3,Dynamin-3,22416,29,1.81 [1.12-2.91],0.0149559853282308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DNMBP,Dynamin-binding protein,25571,33,1.68 [1.12-2.53],0.012725517564618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,25705,33,2.78 [1.57-4.94],0.0004803183870289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DPP4,Dipeptidyl peptidase 4,25241,36,2.70 [1.01-7.27],0.0486115379477921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DPP7,Dipeptidyl peptidase 2,25521,33,1.68 [1.02-2.78],0.0426554841270054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DPY30,Protein dpy-30 homolog,25866,34,1.90 [1.38-2.63],0.0001039368176251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DRAXIN,Draxin,25571,33,2.88 [1.61-5.16],0.0003766170559804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DSC2,Desmocollin-2,25470,35,8.23 [4.58-14.81],1.9589803848016577e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DSCAM,Down syndrome cell adhesion molecule,22416,29,4.55 [1.91-10.80],0.0006027647054442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DSG3,Desmoglein-3,25872,34,4.12 [2.13-7.98],2.6596030072460893e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DTNB,Dystrobrevin beta,22287,28,3.60 [2.38-5.44],1.323294158865753e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DTX2,Probable E3 ubiquitin-protein ligase DTX2,21825,29,0.37 [0.16-0.83],0.0162905128380642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,25620,34,8.51 [4.69-15.47],2.091831448922462e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DUSP29,Dual specificity phosphatase 29,21825,29,1.44 [1.01-2.06],0.0464936267840721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EBI3_IL27,Interleukin-27,25911,34,2.64 [1.23-5.71],0.0132513766064987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,25270,35,3.32 [1.96-5.64],8.670122108619934e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EDN1,Endothelin-1,21875,29,5.20 [2.03-13.34],0.0006055625707129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EDNRB,Endothelin receptor type B,21822,29,1.66 [1.09-2.54],0.0192426673622304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,22348,29,3.85 [2.41-6.18],2.0239625110363186e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFHD1,EF-hand domain-containing protein D1,22416,29,3.17 [2.04-4.93],3.05917918756884e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFNB2,Ephrin-B2,21825,29,1.73 [1.32-2.26],5.8167878579106935e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EGFLAM,Pikachurin,22348,29,3.53 [2.24-5.57],5.940246848765124e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,25743,35,2.13 [1.49-3.04],3.042248340578096e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENAH,Protein enabled homolog,25239,34,2.02 [1.26-3.25],0.0034810725981065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENDOU,Poly(U)-specific endoribonuclease,20740,27,2.03 [1.24-3.34],0.0051090422087569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENOPH1,Enolase-phosphatase E1,22325,29,0.53 [0.30-0.96],0.0368305303776064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,25147,34,2.01 [1.31-3.08],0.001323543225966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPHA1,Ephrin type-A receptor 1,25838,34,2.91 [1.17-7.24],0.0220828535966381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPHA2,Ephrin type-A receptor 2,24828,32,6.66 [4.06-10.91],5.3881088946304775e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPO,Erythropoietin,25705,33,1.58 [1.22-2.04],0.0004471539911689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,25909,34,7.26 [4.03-13.07],3.893320853952039e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ERBB4,Receptor tyrosine-protein kinase erbB-4,25832,34,3.72 [1.79-7.72],0.0004257627111566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ERMAP,Erythroid membrane-associated protein,21822,29,2.06 [1.01-4.24],0.0482714889010652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,26057,36,9.75 [5.37-17.67],6.484286359686993e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EXOSC10,Exosome component 10,21746,28,1.49 [1.01-2.20],0.0465286933232705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EZR,Ezrin,25967,35,3.55 [1.36-9.29],0.0097360674047291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",F10,Coagulation factor X,22460,29,0.31 [0.11-0.83],0.019682366183933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",F2R,Proteinase-activated receptor 1,25832,34,2.05 [1.23-3.42],0.0062246297817653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",F3,Tissue factor,25805,34,7.11 [2.86-17.69],2.439498668553349e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP1,"Fatty acid-binding protein, liver",25753,33,2.37 [1.87-3.00],1.1224246498682117e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",25743,35,2.40 [1.78-3.22],7.392379617394958e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP3,"Fatty acid-binding protein, heart",22457,29,4.10 [2.91-5.78],8.475451873448935e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",26057,36,4.60 [3.10-6.82],3.1399147980250444e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP5,Fatty acid-binding protein 5,25881,35,1.82 [1.27-2.62],0.0011348729519962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP6,Gastrotropin,25230,35,1.81 [1.25-2.60],0.0015414537909315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FAM171B,Protein FAM171B,22325,29,2.26 [1.11-4.60],0.0253678524860232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FAM3B,Protein FAM3B,25620,34,7.16 [2.97-17.29],1.2012352579110123e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FAM3D,Protein FAM3D,22348,29,2.59 [1.67-4.01],2.04856797133364e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,25973,36,2.29 [1.62-3.22],2.1886899326804544e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FBLN2,Fibulin-2,22447,28,9.30 [4.38-19.77],6.779923924374249e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FBN2,Fibrillin-2,21825,29,1.68 [1.06-2.65],0.0268050535266545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,22457,29,2.21 [1.49-3.29],8.566071676555984e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,25705,33,1.95 [1.05-3.64],0.0344163378608857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,22416,29,4.49 [2.07-9.75],0.0001465229902016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCER2,Low affinity immunoglobulin epsilon Fc receptor,25740,35,2.49 [1.79-3.46],7.09568965481001e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,25618,36,3.78 [1.98-7.22],5.677966020829355e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCN2,Ficolin-2,25622,36,0.54 [0.35-0.83],0.0046671271806308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCRL2,Fc receptor-like protein 2,25892,34,2.40 [1.65-3.50],4.417588574765838e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCRL5,Fc receptor-like protein 5,25740,35,2.56 [1.64-4.00],3.696907685020207e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCRLB,Fc receptor-like B,25147,34,1.50 [1.11-2.02],0.0080613618657525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FDX1,"Adrenodoxin, mitochondrial",21746,28,1.52 [1.05-2.18],0.0256361850517803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGF12,Fibroblast growth factor 12,21822,29,1.54 [1.08-2.18],0.0157835593069462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGF23,Fibroblast growth factor 23,25915,34,2.11 [1.64-2.71],4.6839431887245315e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGF5,Fibroblast growth factor 5,25239,34,4.08 [2.66-6.28],1.3820057770489234e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,25832,34,0.28 [0.13-0.62],0.0014227700438454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGL1,Fibrinogen-like protein 1,22460,29,4.40 [2.80-6.92],1.2261213523969218e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FH,"Fumarate hydratase, mitochondrial",21739,29,0.49 [0.24-0.98],0.0432203015798903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,25579,34,3.65 [2.11-6.31],3.685195772782391e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FLT3LG,Fms-related tyrosine kinase 3 ligand,26012,34,3.12 [1.36-7.19],0.0075078718924634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FNDC1,Fibronectin type III domain-containing protein 1,22407,29,7.75 [3.75-16.00],3.1456343681743964e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FOLR2,Folate receptor beta,25967,35,9.72 [4.94-19.13],4.6683240651308175e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FOS,Proto-oncogene c-Fos,21606,29,2.79 [1.46-5.34],0.001915815833297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FSTL1,Follistatin-related protein 1,21875,29,9.14 [3.83-21.83],6.226172453518897e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FSTL3,Follistatin-related protein 3,25706,33,9.52 [5.45-16.61],2.2998852255115188e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FURIN,Furin,25832,34,0.40 [0.16-0.97],0.0417588686549716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,25967,35,4.32 [2.54-7.34],6.585653217380858e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GAD2,Glutamate decarboxylase 2,21822,29,1.67 [1.16-2.42],0.0063738184631705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,25620,34,3.79 [1.55-9.25],0.0034098575839872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,25239,34,2.51 [1.32-4.77],0.0050864844276443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,22457,29,4.44 [1.89-10.41],0.0006177813030766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,21504,27,6.19 [1.61-23.88],0.00812288821007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GASK1A,Golgi-associated kinase 1A,21746,28,0.24 [0.11-0.52],0.0004023644799894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GAST,Gastrin,22407,29,1.35 [1.10-1.65],0.0041215646802787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,21448,27,2.50 [1.83-3.41],9.471543228025156e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",25620,34,3.80 [1.85-7.80],0.0002779811645624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GDF15,Growth/differentiation factor 15,26057,36,3.77 [2.90-4.90],4.942555874750791e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GDNF,Glial cell line-derived neurotrophic factor,25133,33,2.65 [1.64-4.29],7.388744772668925e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GFRA3,GDNF family receptor alpha-3,25493,33,6.89 [3.69-12.85],1.2784708075505306e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GFRAL,GDNF family receptor alpha-like,21720,29,1.80 [1.17-2.75],0.0069382380755802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,25571,33,6.97 [3.81-12.77],3.1685789850487325e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GH1,Somatotropin,25699,35,1.29 [1.09-1.54],0.003302508608523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GIP,Gastric inhibitory polypeptide,21875,29,2.57 [1.58-4.20],0.0001547282155053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GLRX,Glutaredoxin-1,25576,33,1.73 [1.06-2.82],0.0288633581461561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GLYR1,Putative oxidoreductase GLYR1,22325,29,1.53 [1.07-2.21],0.0209366576264346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GM2A,Ganglioside GM2 activator,21902,27,2.14 [1.60-2.86],3.477219707896296e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GOLM2,Protein GOLM2,25967,35,6.41 [2.87-14.36],6.148531996257967e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPHA2,Glycoprotein hormone alpha-2,22348,29,1.69 [1.10-2.59],0.0162624983160896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,22348,29,1.76 [1.04-2.98],0.0338404653219492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPR15L,Protein GPR15L,22348,29,1.92 [1.20-3.06],0.0060744978420427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPR37,Prosaposin receptor GPR37,25270,35,2.91 [1.95-4.34],1.689324767788271e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GRIK2,"Glutamate receptor ionotropic, kainate 2",22416,29,2.02 [1.26-3.25],0.0037501666986208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GRN,Progranulin,25622,35,8.55 [3.60-20.32],1.1778063107975618e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",25620,34,1.69 [1.15-2.48],0.0069859216354386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GSAP,Gamma-secretase-activating protein,25147,34,1.29 [1.04-1.61],0.0221246586394107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GSR,"Glutathione reductase, mitochondrial",22323,29,5.66 [1.92-16.69],0.0016669392757174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GZMB,Granzyme B,25705,33,0.55 [0.32-0.93],0.0272366203836588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,25919,34,3.88 [2.89-5.19],1.0934354874704738e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,25740,35,7.93 [4.75-13.24],2.280605364490826e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HGF,Hepatocyte growth factor,26012,34,3.07 [1.58-5.99],0.0009864076374691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,22366,29,2.28 [1.66-3.14],3.684266653109338e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HJV,Hemojuvelin,22416,29,1.67 [1.08-2.59],0.0218624401505645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",22416,29,6.18 [2.01-18.96],0.0014604029514103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",25630,32,2.86 [1.37-5.98],0.0052736818195969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",25705,33,5.72 [2.89-11.34],5.657509504246101e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HMCN2,Hemicentin-2,21938,28,5.73 [2.99-10.99],1.4653714002747326e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HMOX2,Heme oxygenase 2,25133,33,1.74 [1.10-2.75],0.0173350568029014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HNMT,Histamine N-methyltransferase,25443,33,3.25 [2.07-5.11],2.913164636554299e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,22416,29,1.73 [1.07-2.79],0.0240294129033912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,21875,29,2.54 [1.72-3.74],2.566442886282004e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,25620,34,3.12 [1.59-6.12],0.0009254497366612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,21822,29,8.03 [4.57-14.09],4.198893739871522e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSPA2,Heat shock-related 70 kDa protein 2,22325,29,3.07 [2.08-4.54],1.8422008597857424e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSPB6,Heat shock protein beta-6,25954,34,9.31 [5.84-14.85],6.987858664729156e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HYAL1,Hyaluronidase-1,25579,36,8.09 [3.64-17.97],2.836779936612655e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ICAM1,Intercellular adhesion molecule 1,25621,36,3.65 [1.59-8.41],0.0023049349780793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ICAM3,Intercellular adhesion molecule 3,26057,36,3.60 [1.36-9.50],0.0097420341739171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IDI2,Isopentenyl-diphosphate delta-isomerase 2,25133,33,1.97 [1.36-2.84],0.0003110571986916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,21802,29,3.54 [2.02-6.18],9.133824292366205e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IFNGR2,Interferon gamma receptor 2,25571,33,2.04 [1.20-3.45],0.0083809051129791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,25620,34,4.20 [2.63-6.69],1.6628043129581332e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,26009,36,1.41 [1.10-1.82],0.0071651391428666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,26012,36,6.13 [3.65-10.30],7.887597388903014e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,25397,34,5.56 [3.98-7.77],8.533236277456267e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,25613,36,8.35 [5.27-13.23],1.7402211309141565e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,26057,36,3.73 [2.36-5.90],1.9380142605960122e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,25743,35,5.50 [3.00-10.08],3.707254321104287e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,22447,28,2.19 [1.33-3.60],0.0021042478109189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,25620,34,3.04 [2.12-4.36],1.5433427124594241e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,25743,35,7.65 [4.11-14.23],1.2992449468346698e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,25875,34,5.23 [3.21-8.50],2.6631624913218443e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL12A_IL12B,Interleukin-12,25620,34,1.86 [1.37-2.51],6.567482465328867e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL12B,Interleukin-12 subunit beta,26012,34,2.70 [1.65-4.43],8.333607923107392e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,25239,34,2.41 [1.50-3.86],0.0002744882033883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL15,Interleukin-15,25705,33,3.29 [1.66-6.51],0.0006348266035409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,25239,34,6.18 [2.90-13.14],2.27233050346996e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL16,Pro-interleukin-16,26012,34,2.01 [1.22-3.30],0.0059040075435104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL17C,Interleukin-17C,25239,34,1.82 [1.39-2.37],1.001566722169842e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL17D,Interleukin-17D,25239,34,1.86 [1.11-3.12],0.0191668242782175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL17RA,Interleukin-17 receptor A,25740,35,3.57 [1.90-6.71],7.972104133959505e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL17RB,Interleukin-17 receptor B,25376,33,1.81 [1.03-3.19],0.0405248606257039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL18BP,Interleukin-18-binding protein,25829,36,8.07 [4.67-13.96],7.555819914914435e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL18R1,Interleukin-18 receptor 1,26012,34,9.46 [4.50-19.90],3.1248127135670182e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL18RAP,Interleukin-18 receptor accessory protein,25414,33,1.21 [1.04-1.41],0.0163622388941963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL19,Interleukin-19,25098,35,2.01 [1.49-2.71],4.140709898712345e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,25973,36,4.23 [2.40-7.46],6.148776191003259e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL22,Interleukin-22,22325,29,1.82 [1.31-2.53],0.0003826639737548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL22RA1,Interleukin-22 receptor subunit alpha-1,25239,34,1.59 [1.04-2.44],0.0328216085835245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,25535,36,5.27 [3.31-8.40],2.8214546076900866e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL34,Interleukin-34,25093,33,3.06 [1.27-7.36],0.0124529390547129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL36A,Interleukin-36 alpha,21822,29,1.49 [1.01-2.19],0.0439840184176716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL36G,Interleukin-36 gamma,21723,29,1.49 [1.05-2.10],0.0248463415540328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL4,Interleukin-4,25239,34,0.77 [0.62-0.97],0.0242564593127195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,25705,33,4.51 [3.00-6.79],4.72948250091786e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL5RA,Interleukin-5 receptor subunit alpha,25705,33,1.76 [1.11-2.79],0.0156211417086286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL6R,Interleukin-6 receptor subunit alpha,25573,36,4.23 [1.85-9.68],0.0006370980400274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,25743,35,9.33 [2.85-30.55],0.0002247129666353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IMMT,MICOS complex subunit MIC60,22325,29,2.03 [1.28-3.22],0.002664320131785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",INHBB,Inhibin beta B chain,21977,28,4.33 [2.52-7.44],1.1758501949434669e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",INHBC,Inhibin beta C chain,25740,35,0.45 [0.24-0.87],0.0166112914175777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",INSL4,Early placenta insulin-like peptide,22325,29,1.57 [1.16-2.12],0.0036179844040323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ISM1,Isthmin-1,25705,33,2.33 [1.18-4.60],0.0147399892563742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGA5,Integrin alpha-5,25740,35,6.90 [2.54-18.74],0.0001484769448433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGAM,Integrin alpha-M,25740,35,5.41 [2.61-11.20],5.582488981402487e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGB1,Integrin beta-1,25701,36,3.46 [1.22-9.83],0.0197287726543034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGB2,Integrin beta-2,25578,36,8.88 [3.96-19.93],1.1878369642570605e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGB5,Integrin beta-5,25832,34,2.48 [1.34-4.61],0.0040124862789615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGB6,Integrin beta-6,25239,34,4.42 [1.69-11.60],0.0025093753570045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGB7,Integrin beta-7,25954,34,2.61 [1.57-4.34],0.0002256271595894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGBL1,Integrin beta-like protein 1,22447,28,3.75 [1.79-7.86],0.0004550185548268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,25829,36,9.00 [4.29-18.89],6.415675575683964e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITM2A,Integral membrane protein 2A,25705,33,1.72 [1.05-2.81],0.0312972769256926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",JAM3,Junctional adhesion molecule C,21977,28,2.23 [1.36-3.66],0.0014472764599816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",JCHAIN,Immunoglobulin J chain,25239,34,1.80 [1.16-2.80],0.0084173481349658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",JUN,Transcription factor AP-1,25239,34,1.51 [1.06-2.14],0.0216566848233628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,25620,34,2.87 [1.40-5.87],0.0039082286563752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KIAA0319,Dyslexia-associated protein KIAA0319,22407,29,2.84 [1.61-5.02],0.00031526173947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KIF1C,Kinesin-like protein KIF1C,21746,28,2.12 [1.44-3.12],0.0001388622453197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,25147,34,1.70 [1.19-2.45],0.0039308890151897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLF4,Krueppel-like factor 4,21739,29,2.15 [1.25-3.72],0.005892030562463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK10,Kallikrein-10,25747,34,2.08 [1.25-3.46],0.0045955334777205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK11,Kallikrein-11,25593,34,3.91 [2.69-5.70],1.115396263382201e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK4,Kallikrein-4,25954,34,4.09 [3.17-5.28],1.62864524707258e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK6,Kallikrein-6,25795,34,7.85 [3.26-18.93],4.382175231769445e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK8,Kallikrein-8,24895,33,3.58 [2.01-6.38],1.4803618937774783e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLRD1,Natural killer cells antigen CD94,26012,34,3.65 [2.05-6.51],1.1220682832316604e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLRF1,Killer cell lectin-like receptor subfamily F member 1,21822,29,1.65 [1.06-2.59],0.0276530813939234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLRK1,NKG2-D type II integral membrane protein,22407,29,2.20 [1.25-3.87],0.00643240138246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",25620,34,1.73 [1.28-2.34],0.0003994992147558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",25669,33,2.51 [1.91-3.31],5.5689702999963126e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",21739,29,1.63 [1.25-2.12],0.0002762313344777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",L1CAM,Neural cell adhesion molecule L1,25832,34,5.18 [1.96-13.72],0.0009312276073777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAG3,Lymphocyte activation gene 3 protein,25620,34,2.26 [1.35-3.78],0.0020381061705846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,25753,33,3.66 [2.28-5.89],8.127411904362893e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAMA4,Laminin subunit alpha-4,25875,34,4.35 [2.32-8.16],4.330725415557041e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAMB1,Laminin subunit beta-1,21875,29,4.91 [1.47-16.40],0.0096316020290546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,25968,34,2.03 [1.20-3.42],0.0081652748302212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LBR,Delta(14)-sterol reductase LBR,25967,35,1.48 [1.09-2.00],0.0112397294949249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LCAT,Phosphatidylcholine-sterol acyltransferase,22460,29,0.36 [0.18-0.72],0.0042284217683418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LCN15,Lipocalin-15,22416,29,1.69 [1.25-2.28],0.0005636157444024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,24957,36,4.08 [2.75-6.06],2.986334254655753e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,22457,29,1.79 [1.21-2.67],0.0039030828204872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LEFTY2,Left-right determination factor 2,25911,34,1.91 [1.11-3.30],0.0197419386254653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LEP,Leptin,25743,35,2.54 [1.45-4.46],0.0011747652463139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LEPR,Leptin receptor,25743,35,3.97 [2.51-6.27],3.8853941639266325e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,22416,29,2.13 [1.35-3.35],0.0011079170901849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS1,Galectin-1,25743,35,5.88 [3.35-10.32],6.610917037457983e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS3,Galectin-3,25802,36,4.65 [2.59-8.34],2.461533936038782e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS4,Galectin-4,25753,33,5.65 [3.82-8.36],4.688303318086471e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS9,Galectin-9,25748,34,7.04 [3.65-13.57],5.923960887695476e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGMN,Legumain,25875,34,3.01 [1.40-6.47],0.0048328443409562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LIFR,Leukemia inhibitory factor receptor,25705,33,8.06 [4.20-15.47],3.41912372613321e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,25699,35,7.21 [3.30-15.77],7.508576287400847e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,22457,29,2.26 [1.33-3.82],0.0024206207155224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,25239,34,3.63 [2.11-6.26],3.4780333545944008e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LMNB2,Lamin-B2,22407,29,5.48 [3.20-9.39],5.529824176475233e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LMOD1,Leiomodin-1,22416,29,3.37 [2.41-4.73],1.7960920646068269e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LPCAT2,Lysophosphatidylcholine acyltransferase 2,25620,34,1.57 [1.08-2.27],0.017650529449779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LPO,Lactoperoxidase,24951,33,2.59 [1.82-3.69],1.424747910334818e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,22491,28,5.30 [2.16-12.99],0.0002711893947743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,25876,34,4.01 [1.91-8.40],0.0002349683205425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,21737,29,2.15 [1.10-4.22],0.0253163339848201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,25743,35,9.63 [5.20-17.87],6.515130349156063e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,25620,34,2.44 [1.51-3.93],0.0002488728589599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LSP1,Lymphocyte-specific protein 1,25705,33,2.25 [1.18-4.27],0.0134185131795574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,26057,36,7.26 [4.03-13.05],3.631603374345411e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,25147,34,1.89 [1.41-2.52],1.7815441876024738e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LUZP2,Leucine zipper protein 2,22325,29,2.00 [1.40-2.87],0.0001485121712271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LY6D,Lymphocyte antigen 6D,25626,33,3.71 [2.36-5.83],1.2985612847613664e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,25468,34,7.39 [3.35-16.28],6.993180509216995e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LY96,Lymphocyte antigen 96,25571,33,3.26 [2.02-5.26],1.2271352463697797e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LYPD3,Ly6/PLAUR domain-containing protein 3,25630,34,2.39 [1.20-4.77],0.0131970049618602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LYPLA2,Acyl-protein thioesterase 2,21739,29,1.26 [1.00-1.58],0.0461084249596514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,25482,33,1.83 [1.35-2.48],9.890445173010729e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAMDC2,MAM domain-containing protein 2,22457,29,7.39 [3.89-14.03],9.719740475064131e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAPK13,Mitogen-activated protein kinase 13,21644,29,1.67 [1.01-2.77],0.044682670768307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAPT,Microtubule-associated protein tau,25133,33,2.15 [1.34-3.43],0.0014414316059712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MARCO,Macrophage receptor MARCO,25743,35,6.18 [2.36-16.17],0.0002036234106032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MATN2,Matrilin-2,25797,33,7.22 [3.08-16.95],5.558411857363819e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MATN3,Matrilin-3,25532,33,0.41 [0.20-0.81],0.0099729648968779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MB,Myoglobin,26057,36,2.78 [2.01-3.84],5.478625965896924e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MCAM,Cell surface glycoprotein MUC18,25829,36,5.67 [3.18-10.10],3.9134523721773015e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,25639,35,2.11 [1.10-4.04],0.0247215386072652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,25571,33,1.64 [1.04-2.59],0.0342375185171214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MDH1,"Malate dehydrogenase, cytoplasmic",22324,29,2.08 [1.07-4.03],0.0303089672360498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MDK,Midkine,25756,34,2.05 [1.58-2.67],7.574368302387253e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MEGF10,Multiple epidermal growth factor-like domains protein 10,25753,33,4.55 [2.10-9.86],0.0001211248721397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MERTK,Tyrosine-protein kinase Mer,26012,34,7.60 [3.25-17.76],2.77404767672433e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MFAP5,Microfibrillar-associated protein 5,26057,36,7.48 [3.99-14.02],3.3226620302684247e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MFGE8,Lactadherin,25740,35,3.75 [2.01-7.01],3.3974212823264305e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MILR1,Allergin-1,25239,34,2.86 [1.84-4.46],3.4459399175085503e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MME,Neprilysin,25620,34,1.52 [1.10-2.10],0.0112298696274818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP10,Stromelysin-2,25710,33,2.33 [1.65-3.29],1.5310493170875187e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP12,Macrophage metalloelastase,25750,34,3.73 [2.48-5.61],2.2929395556934126e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP13,Collagenase 3,25133,33,7.04 [3.56-13.95],2.1948647270737525e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP3,Stromelysin-1,25740,35,2.44 [1.62-3.67],1.7225255189026413e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP7,Matrilysin,25226,35,4.80 [2.71-8.50],7.28120234049776e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP8,Neutrophil collagenase,25923,35,1.56 [1.11-2.20],0.0112637559171786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MOG,Myelin-oligodendrocyte glycoprotein,25954,34,7.92 [3.74-16.77],6.605633228185375e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MPO,Myeloperoxidase,25740,35,2.05 [1.28-3.27],0.0027746871983592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MRC1,Macrophage mannose receptor 1,22460,29,6.75 [2.85-15.98],1.3820223571616135e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MSMB,Beta-microseminoprotein,25651,35,1.98 [1.32-2.97],0.0010350078353456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,25967,35,4.46 [2.74-7.26],1.8975712439135237e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MSTN,Growth/differentiation factor 8,25270,35,2.02 [1.21-3.38],0.0074330919328169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MUC13,Mucin-13,25133,33,4.34 [2.98-6.34],2.72526680970628e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MUC2,Mucin-2,22447,28,2.16 [1.53-3.04],1.1749672065831648e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MXRA8,Matrix remodeling-associated protein 8,21977,28,3.89 [1.26-12.02],0.0184274010077059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYBPC1,"Myosin-binding protein C, slow-type",22457,29,2.46 [1.78-3.40],4.596660049419113e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYBPC2,"Myosin-binding protein C, fast-type",21875,29,1.69 [1.40-2.03],3.7082491844706414e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",21746,28,1.56 [1.02-2.39],0.0395079583608052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYL3,Myosin light chain 3,21875,29,2.49 [1.65-3.76],1.3530783738477568e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYL4,Myosin light chain 4,21875,29,2.08 [1.46-2.97],5.68764849085124e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",21825,29,2.09 [1.49-2.93],1.83158427849468e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYOC,Myocilin,25740,35,2.21 [1.25-3.92],0.006676084562683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYOM2,Myomesin-2,21746,28,2.11 [1.39-3.19],0.0004016080443227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYOM3,Myomesin-3,21977,28,2.20 [1.56-3.11],7.146917386902319e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,25840,33,2.75 [1.76-4.30],8.202631866030336e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NADK,NAD kinase,25743,35,1.59 [1.09-2.32],0.0166540916293178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NAGK,N-acetyl-D-glucosamine kinase,21835,29,0.50 [0.25-0.97],0.0401928637410182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NCAM1,Neural cell adhesion molecule 1,25829,36,4.46 [1.90-10.49],0.0006116226029942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NCAM2,Neural cell adhesion molecule 2,25740,35,4.38 [1.71-11.22],0.0021178197553683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NCAN,Neurocan core protein,25967,35,0.40 [0.19-0.86],0.0187772780395255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NCR1,Natural cytotoxicity triggering receptor 1,25666,33,9.63 [5.25-17.70],2.8238714367582813e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NDRG1,Protein NDRG1,25133,33,1.43 [1.10-1.86],0.0071621904452183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NECTIN4,Nectin-4,25832,34,6.60 [4.41-9.88],4.632603036760353e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NEFL,Neurofilament light polypeptide,25050,33,5.13 [3.63-7.25],1.8369013872202222e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,25832,34,0.19 [0.10-0.34],5.6827450805199176e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NELL2,Protein kinase C-binding protein NELL2,25875,34,6.84 [3.22-14.52],5.641564545782961e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NEO1,Neogenin,22416,29,4.07 [2.05-8.06],6.011448034339691e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NFYA,Nuclear transcription factor Y subunit alpha,21746,28,1.82 [1.08-3.08],0.0247449679694585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NGFR,Tumor necrosis factor receptor superfamily member 16,22457,29,2.36 [1.42-3.91],0.0008698417118839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NHLRC3,NHL repeat-containing protein 3,21442,27,5.13 [1.57-16.75],0.0066934229010064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NID1,Nidogen-1,25738,36,2.38 [1.21-4.67],0.0117698513063146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,25571,33,1.36 [1.02-1.82],0.0353932519374213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NOS1,"Nitric oxide synthase, brain",25133,33,4.04 [2.79-5.87],1.75037605401592e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",25133,33,1.66 [1.16-2.38],0.005235864162271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NOTCH2,Neurogenic locus notch homolog protein 2,22447,28,4.84 [1.41-16.66],0.0123249357378278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,26057,36,2.81 [1.27-6.18],0.0103864125289719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,22063,28,3.83 [2.55-5.76],1.0055370973949879e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,25743,35,7.62 [4.93-11.76],4.894014032686871e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPHS1,Nephrin,21822,29,0.23 [0.07-0.71],0.0101911787736537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPHS2,Podocin,21822,29,1.32 [1.03-1.69],0.0302736001433089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPPB,Natriuretic peptides B,25270,35,1.31 [1.03-1.66],0.025302465570489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPPC,C-type natriuretic peptide,25705,33,2.40 [1.51-3.82],0.0002165195517743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPTX1,Neuronal pentraxin-1,25740,35,2.01 [1.04-3.86],0.0373272728032742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPTX2,Neuronal pentraxin-2,22447,28,2.81 [1.01-7.83],0.0482432299287311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPTXR,Neuronal pentraxin receptor,25743,35,2.45 [1.29-4.64],0.0059639859227032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPY,Pro-neuropeptide Y,25954,34,2.01 [1.22-3.32],0.0063290835748749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NRCAM,Neuronal cell adhesion molecule,25743,35,8.67 [4.52-16.65],8.612951212302407e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NRP2,Neuropilin-2,25740,35,3.33 [1.68-6.60],0.000578656898236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NSFL1C,NSFL1 cofactor p47,25967,35,1.56 [1.02-2.39],0.0391311487552657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,22407,29,2.71 [1.85-3.95],2.4257654875844454e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NTF3,Neurotrophin-3,25705,33,2.29 [1.32-3.96],0.0032091519971446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,25743,35,1.99 [1.58-2.50],2.9559796852866517e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NUCB2,Nucleobindin-2,25906,34,3.05 [1.50-6.21],0.0020799251061877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NUDT5,ADP-sugar pyrophosphatase,25740,35,1.75 [1.07-2.86],0.0265983679665184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NXPH1,Neurexophilin-1,25133,33,2.30 [1.58-3.35],1.3797548006549309e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NXPH3,Neurexophilin-3,21822,29,7.48 [3.03-18.46],1.2536102939946548e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OBP2B,Odorant-binding protein 2b,25490,33,1.88 [1.17-3.01],0.0089294811896476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OCLN,Occludin,22416,29,4.51 [2.87-7.07],5.4527220599867305e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OLFM4,Olfactomedin-4,21155,26,2.08 [1.61-2.69],1.785902857265683e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,25489,35,1.67 [1.14-2.45],0.008183848366357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OMP,Olfactory marker protein,21739,29,1.72 [1.14-2.61],0.0099723500829346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OPTC,Opticin,25620,34,1.60 [1.03-2.47],0.0368788501372579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OSBPL2,Oxysterol-binding protein-related protein 2,22407,29,2.11 [1.45-3.08],0.000107318165448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,25797,33,3.86 [1.59-9.36],0.0027904739643205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,25874,36,6.22 [1.69-22.95],0.0060141126032853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PADI2,Protein-arginine deiminase type-2,25239,34,1.43 [1.02-1.99],0.0355841314503833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PADI4,Protein-arginine deiminase type-4,25093,33,1.34 [1.01-1.77],0.0414791601637589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PALM,Paralemmin-1,22232,28,8.80 [4.92-15.74],2.2381079844670174e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PALM2,Paralemmin-2,22407,29,5.49 [3.58-8.44],7.300471534475006e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PAM,Peptidyl-glycine alpha-amidating monooxygenase,25912,36,5.98 [1.87-19.17],0.002612880534675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PBK,Lymphokine-activated killer T-cell-originated protein kinase,21644,29,2.90 [1.12-7.47],0.0279731250424159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,22348,29,2.48 [1.37-4.48],0.0028022479879614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCDH1,Protocadherin-1,25930,34,4.17 [2.30-7.57],2.764093643824006e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCDH12,Protocadherin-12,22416,29,3.07 [1.35-6.98],0.007479455105807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCDH17,Protocadherin-17,25743,35,6.10 [3.48-10.69],2.52789592026096e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCDH7,Protocadherin-7,22348,29,2.46 [1.62-3.75],2.5767260490128205e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCDH9,Protocadherin-9,22348,29,4.22 [1.76-10.11],0.0012366657483917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCDHB15,Protocadherin beta-15,22325,29,2.69 [1.74-4.17],8.923414336453059e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,26057,36,2.58 [1.25-5.32],0.0105273042090044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDCD1,Programmed cell death protein 1,25917,34,3.10 [2.11-4.55],8.510205828837155e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,25620,34,6.55 [4.03-10.65],3.701834508084835e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDCD5,Programmed cell death protein 5,25967,35,2.07 [1.32-3.26],0.001666456982259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",21644,29,1.56 [1.15-2.12],0.004406940348476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDGFRB,Platelet-derived growth factor receptor beta,26057,36,3.28 [1.32-8.13],0.0104324300268269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDIA3,Protein disulfide-isomerase A3,21977,28,2.56 [1.59-4.13],0.0001203929597242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,21822,29,2.26 [1.38-3.68],0.0011627171121612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PEAR1,Platelet endothelial aggregation receptor 1,26057,36,7.82 [2.31-26.49],0.0009454528912607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PEBP1,Phosphatidylethanolamine-binding protein 1,25740,35,1.86 [1.18-2.93],0.0075162432386889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PENK,Proenkephalin-A,21977,28,3.68 [2.32-5.84],2.9538801833286562e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",22457,29,1.88 [1.04-3.41],0.0365502688112504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PGF,Placenta growth factor,26012,34,4.12 [2.75-6.19],7.155091793349339e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,25928,36,2.49 [1.53-4.05],0.0002406468470923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,22348,29,2.51 [1.50-4.18],0.0004203858767355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,25571,33,7.38 [3.47-15.70],2.117396880844156e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PI3,Elafin,25388,36,2.57 [1.96-3.39],1.3369315147238419e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PIGR,Polymeric immunoglobulin receptor,25406,35,9.94 [5.62-17.60],3.176232565327892e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,25740,35,7.19 [3.91-13.23],2.1763523940202447e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,25743,35,4.90 [2.72-8.83],1.270739846138689e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLA2G10,Group 10 secretory phospholipase A2,25571,33,1.99 [1.21-3.27],0.0067707799688967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLA2G15,Phospholipase A2 group XV,25832,34,4.92 [1.81-13.37],0.0017659526322678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLA2G1B,Phospholipase A2,26010,36,0.24 [0.14-0.41],1.1568993498781748e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,25740,35,0.29 [0.18-0.49],1.8935204938058128e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLIN3,Perilipin-3,25743,35,2.76 [1.59-4.77],0.0002848803601213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLTP,Phospholipid transfer protein,25964,36,3.40 [1.37-8.44],0.0085079889349973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLXDC2,Plexin domain-containing protein 2,22407,29,3.10 [1.78-5.42],6.727590858243379e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PMS1,PMS1 protein homolog 1,21825,29,1.70 [1.03-2.81],0.0371339356893474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PNLIP,Pancreatic triacylglycerol lipase,22460,29,0.24 [0.16-0.37],1.2043705057722503e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PNLIPRP1,Inactive pancreatic lipase-related protein 1,22407,29,0.51 [0.33-0.78],0.0021028286387574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PODXL2,Podocalyxin-like protein 2,25832,34,2.92 [1.12-7.60],0.0286311785431728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",POF1B,Protein POF1B,21822,29,2.82 [2.04-3.90],3.1620493264161126e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",25620,34,2.22 [1.48-3.35],0.0001340306745459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,22460,29,0.38 [0.16-0.92],0.0318594958018996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",POSTN,Periostin,22447,28,2.84 [1.45-5.57],0.002412632237723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPL,Periplakin,21822,29,2.56 [1.56-4.19],0.0001847252839481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPM1A,Protein phosphatase 1A,25147,34,1.89 [1.05-3.39],0.0336247329419017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,22416,29,2.39 [1.48-3.87],0.0004013405513917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRAP1,Proline-rich acidic protein 1,22447,28,7.45 [2.91-19.09],2.887819672927953e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,25895,36,3.93 [2.48-6.23],5.629132982854956e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PREB,Prolactin regulatory element-binding protein,25239,34,2.15 [1.26-3.68],0.0052423347890686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRG2,Bone marrow proteoglycan,22447,28,3.79 [2.35-6.13],4.950823472715867e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,25239,34,1.61 [1.03-2.52],0.035939418473508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRL,Prolactin,25967,35,1.71 [1.26-2.32],0.0005581818875909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRND,Prion-like protein doppel,22407,29,2.99 [1.92-4.66],1.2460629406768863e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PROS1,Vitamin K-dependent protein S,22491,28,0.17 [0.05-0.59],0.0052157647107402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRR4,Proline-rich protein 4,21822,27,1.69 [1.08-2.65],0.0208341580732964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRRT3,Proline-rich transmembrane protein 3,21875,29,4.92 [2.52-9.61],3.074963675612762e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRSS27,Serine protease 27,25659,35,4.29 [2.32-7.92],3.2753470124175344e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRSS8,Prostasin,25661,34,4.55 [2.44-8.46],1.7481589296452367e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRTG,Protogenin,25954,34,9.86 [3.91-24.85],1.2396062993476395e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRTN3,Myeloblastin,25071,36,1.83 [1.20-2.80],0.0053137389287693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSAP,Prosaposin,22229,28,3.20 [1.91-5.38],1.0600365150980957e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSCA,Prostate stem cell antigen,22348,29,1.21 [1.01-1.44],0.0334507246393288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,25571,33,2.87 [2.19-3.75],1.7559023417610587e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSMD1,26S proteasome non-ATPase regulatory subunit 1,22416,29,2.35 [1.48-3.72],0.0002733181729856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSME2,Proteasome activator complex subunit 2,25451,32,2.53 [1.15-5.55],0.0207265316937524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,25532,36,8.85 [5.91-13.24],3.026382312745014e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,25705,33,1.81 [1.25-2.61],0.0015277030721971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,25133,33,4.24 [2.79-6.45],1.4354352912823093e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTN,Pleiotrophin,25270,35,1.82 [1.09-3.04],0.0222132291855331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,21776,29,1.82 [1.05-3.14],0.0318375713985802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,22457,29,3.32 [1.43-7.73],0.0052806815337983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPRC,Receptor-type tyrosine-protein phosphatase C,22447,28,5.47 [2.16-13.87],0.0003454729080634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPRF,Receptor-type tyrosine-protein phosphatase F,26057,36,2.96 [1.09-8.03],0.0330208361118732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,22348,29,3.03 [1.34-6.82],0.0075809627403256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPRR,Receptor-type tyrosine-protein phosphatase R,22407,29,2.65 [1.26-5.54],0.0098343962937665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,22457,29,5.47 [2.15-13.96],0.0003703434562191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTS,6-pyruvoyl tetrahydrobiopterin synthase,25023,33,1.72 [1.09-2.71],0.0197922414886733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTTG1,Securin,22028,29,1.67 [1.05-2.67],0.0312125948145133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PVR,Poliovirus receptor,25967,35,2.09 [1.04-4.19],0.0373370932698507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PXN,Paxillin,25133,33,1.62 [1.08-2.44],0.0203400048398102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PYY,Peptide YY,21746,28,1.62 [1.17-2.25],0.0035946682252983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PZP,Pregnancy zone protein,22491,28,0.44 [0.24-0.83],0.0112585482347648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,25775,36,8.06 [4.41-14.71],1.1358089594197854e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RAB44,Ras-related protein Rab-44,22325,29,1.63 [1.08-2.45],0.0188876673082066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RABGAP1L,Rab GTPase-activating protein 1-like,25239,34,1.73 [1.13-2.64],0.0111404608178265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RAD51,DNA repair protein RAD51 homolog 1,22028,29,1.45 [1.02-2.06],0.0386868714605063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RARRES1,Retinoic acid receptor responder protein 1,25147,34,1.77 [1.12-2.80],0.0144878268321463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,25874,36,1.94 [1.19-3.14],0.0073626552400982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RASSF2,Ras association domain-containing protein 2,25147,34,1.50 [1.09-2.08],0.0130424423987087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,22416,29,3.63 [2.58-5.11],1.4009373217616597e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBP1,Retinol-binding protein 1,21825,29,1.56 [1.18-2.05],0.0015609169052001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBP2,Retinol-binding protein 2,25620,34,2.79 [2.05-3.79],6.912842335314124e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBP5,Retinol-binding protein 5,25620,34,2.13 [1.42-3.18],0.0002258993746341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBP7,Retinoid-binding protein 7,22348,29,2.09 [1.46-2.98],4.901286149916957e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG1A,Lithostathine-1-alpha,25576,36,3.83 [2.90-5.07],3.640546940072673e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG1B,Lithostathine-1-beta,26057,36,2.53 [1.88-3.40],7.090749812165819e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,26057,36,3.18 [2.32-4.37],8.796248770897867e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG4,Regenerating islet-derived protein 4,25797,33,7.13 [4.64-10.96],3.1805684904027456e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REN,Renin,25743,35,3.45 [2.77-4.30],3.790280801790303e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,25620,34,3.79 [1.94-7.42],0.0001003215073583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RETN,Resistin,25675,36,3.84 [2.52-5.87],4.6154048546016557e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,21977,28,2.47 [1.52-4.01],0.000258546482694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASE1,Ribonuclease pancreatic,22460,29,4.64 [2.77-7.75],4.8466718979576075e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,21875,29,2.08 [1.53-2.84],3.5781006023424884e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASE3,Eosinophil cationic protein,25621,35,1.42 [1.19-1.70],0.0001290477957478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASE4,Ribonuclease 4,21704,28,3.90 [2.13-7.12],9.645407598626568e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASE6,Ribonuclease K6,22292,29,3.30 [2.38-4.57],7.522192743017839e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASET2,Ribonuclease T2,25931,36,7.48 [4.47-12.53],2.0619326691927204e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,21875,29,6.71 [3.10-14.53],1.3576028626927685e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ROBO1,Roundabout homolog 1,25797,33,8.34 [4.00-17.38],1.513554767220429e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ROBO2,Roundabout homolog 2,25967,35,7.04 [2.75-18.02],4.665507879049003e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RSPO1,R-spondin-1,25571,33,2.64 [1.49-4.67],0.0008580628740272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RSPO3,R-spondin-3,25954,34,9.73 [4.97-19.02],3.0003465251043736e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RTBDN,Retbindin,25620,34,4.62 [2.25-9.51],3.197080012801655e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RTN4R,Reticulon-4 receptor,25954,34,2.60 [1.65-4.12],4.318743940341325e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",S100A11,Protein S100-A11,25535,35,1.67 [1.12-2.49],0.01140314160838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",S100A13,Protein S100-A13,21822,29,2.70 [1.58-4.63],0.0002924706519418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",S100G,Protein S100-G,22416,29,2.01 [1.04-3.88],0.0373529525437017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",S100P,Protein S100-P,25270,35,2.04 [1.53-2.72],1.0226765332846262e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCARB2,Lysosome membrane protein 2,25104,33,8.92 [5.67-14.04],2.9024906568494335e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCARF1,Scavenger receptor class F member 1,26057,36,2.86 [1.57-5.22],0.0006129043642853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCG3,Secretogranin-3,25797,33,3.45 [1.44-8.24],0.0053985209267639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCGB1A1,Uteroglobin,25788,34,3.79 [2.05-7.03],2.256581384139261e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,25832,34,1.27 [1.01-1.60],0.0370990553694498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCGN,Secretagogin,25239,34,3.93 [2.67-5.77],3.167079670373741e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCN4B,Sodium channel subunit beta-4,21875,29,5.36 [2.97-9.67],2.3245040043759056e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCRG1,Scrapie-responsive protein 1,22457,29,5.33 [2.74-10.35],7.706910888879971e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCT,Secretin,21825,29,1.89 [1.03-3.48],0.0406286328872711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SDC1,Syndecan-1,25743,35,2.75 [1.83-4.15],1.305981859749205e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SDK2,Protein sidekick-2,21977,28,2.25 [1.26-4.03],0.0063172574486065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEL1L,Protein sel-1 homolog 1,21875,29,2.58 [1.81-3.67],1.582361895576414e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SELL,L-selectin,22491,28,0.25 [0.06-0.95],0.042166968556627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEMA7A,Semaphorin-7A,25973,36,5.07 [3.17-8.10],1.079278579946732e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEPTIN3,Neuronal-specific septin-3,22416,29,1.59 [1.14-2.23],0.0066863347941662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEPTIN8,Septin-8,22362,29,5.36 [3.11-9.22],1.425723373047025e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINA11,Serpin A11,26057,36,2.36 [1.11-4.99],0.0249565106518387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINB8,Serpin B8,26012,34,1.47 [1.03-2.08],0.032589112304674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINF1,Pigment epithelium-derived factor,22157,27,5.21 [2.07-13.09],0.0004470010277485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINI2,Serpin I2,22348,29,0.33 [0.15-0.71],0.0047222145857152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEZ6,Seizure protein 6 homolog,21825,29,3.09 [1.69-5.65],0.0002485119449759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEZ6L2,Seizure 6-like protein 2,25620,34,4.19 [1.59-11.06],0.0038249986749948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SFRP1,Secreted frizzled-related protein 1,25492,33,2.64 [1.78-3.89],1.1263665570974103e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SFRP4,Secreted frizzled-related protein 4,21977,28,9.18 [4.19-20.10],2.956244509829216e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SHISA5,Protein shisa-5,22447,28,5.14 [3.11-8.48],1.5216024767153912e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIAE,Sialate O-acetylesterase,25789,34,1.88 [1.03-3.42],0.0396993378713517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC1,Sialoadhesin,25875,34,4.04 [2.44-6.70],6.041809738507998e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,25705,33,5.05 [3.03-8.41],4.730698980163324e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,25954,34,3.25 [2.01-5.26],1.5453790194104365e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,25743,35,5.91 [2.87-12.18],1.4329798379617474e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,21875,29,4.44 [2.30-8.58],9.021460720417075e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,25809,36,3.35 [1.66-6.76],0.0007517284581819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,25716,33,5.49 [3.22-9.38],4.4687026285839183e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,25239,34,2.54 [1.64-3.93],2.888906966773276e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLAMF6,SLAM family member 6,25147,34,2.70 [1.37-5.31],0.0040165279373524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLAMF7,SLAM family member 7,25705,33,1.85 [1.16-2.94],0.0096535090546973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLAMF8,SLAM family member 8,25147,34,3.16 [2.01-4.97],5.724373824517442e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLC16A1,Monocarboxylate transporter 1,25133,33,1.51 [1.08-2.11],0.0160524830350987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLC39A14,Zinc transporter ZIP14,25133,33,2.79 [1.80-4.34],5.048430634496136e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,22348,29,1.48 [1.04-2.11],0.0296249223188556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,21822,29,2.82 [1.00-7.93],0.0499962079379746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,25270,35,3.33 [2.07-5.35],6.402651616275498e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLURP1,Secreted Ly-6/uPAR-related protein 1,22284,28,1.73 [1.03-2.91],0.038090118041684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMC3,Structural maintenance of chromosomes protein 3,21644,29,0.36 [0.15-0.84],0.0181631591847981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,25954,34,8.02 [4.19-15.33],3.1965286283723576e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,25875,34,5.17 [3.38-7.91],3.4744429202771145e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,25847,35,2.45 [1.44-4.17],0.0009450698587493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNAPIN,SNARE-associated protein Snapin,22416,29,0.42 [0.21-0.83],0.0122234975300145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNCG,Gamma-synuclein,25571,33,5.42 [3.63-8.10],1.7080666905338212e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",21875,29,2.07 [1.06-4.03],0.0325167454516352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNRPB2,U2 small nuclear ribonucleoprotein B'',22407,29,1.78 [1.31-2.42],0.0002404781682238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNX9,Sorting nexin-9,25743,35,1.70 [1.15-2.52],0.0079552639403461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SOD1,Superoxide dismutase [Cu-Zn],25206,36,2.11 [1.29-3.46],0.0029844554657734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SORBS1,Sorbin and SH3 domain-containing protein 1,22416,29,2.01 [1.37-2.95],0.0003584421036014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,25147,34,5.82 [3.55-9.55],3.1729313562307253e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SOST,Sclerostin,25699,35,3.70 [1.93-7.06],7.605015863214524e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SOX9,Transcription factor SOX-9,21825,29,6.74 [2.83-16.05],1.6784505510231836e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,22416,29,2.31 [1.23-4.34],0.0089809701174004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPARCL1,SPARC-like protein 1,25752,36,2.93 [1.68-5.10],0.0001460952807832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,25740,35,3.81 [2.64-5.49],8.17707830357242e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,21977,28,3.46 [1.69-7.10],0.0007144709805131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,25705,33,3.20 [2.32-4.41],1.3119080258357253e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK5,Serine protease inhibitor Kazal-type 5,25740,35,4.72 [2.20-10.15],6.947082291944972e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,25954,34,1.87 [1.06-3.31],0.0316448743591644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,25664,35,3.79 [1.92-7.49],0.0001255294854013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,25875,34,4.19 [2.09-8.39],5.3000510062028815e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPOCK1,Testican-1,25571,33,0.15 [0.05-0.51],0.0023116837411065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPON1,Spondin-1,25797,33,3.96 [2.44-6.43],2.4027811334164643e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPP1,Osteopontin,26012,36,4.73 [3.02-7.40],1.0091416784196111e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPRR3,Small proline-rich protein 3,22407,29,1.65 [1.07-2.54],0.0232474535969268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,22457,29,9.98 [4.99-19.95],7.544251969773336e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",25620,34,1.76 [1.07-2.90],0.0273207047266252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STC1,Stanniocalcin-1,25967,35,4.01 [2.71-5.93],4.10112014369585e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STC2,Stanniocalcin-2,25705,34,4.28 [1.71-10.70],0.0019097978452949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SUSD2,Sushi domain-containing protein 2,25740,35,2.80 [1.53-5.11],0.0008264746706639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SUSD4,Sushi domain-containing protein 4,22325,29,1.95 [1.19-3.21],0.0084717637070971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SUSD5,Sushi domain-containing protein 5,21844,28,9.28 [3.65-23.62],2.9377794127644696e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SYT1,Synaptotagmin-1,22407,29,1.70 [1.03-2.80],0.038411189575249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,22813,31,2.39 [1.39-4.14],0.0017674180504933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,25620,34,8.49 [5.36-13.46],8.924645888758353e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TBC1D17,TBC1 domain family member 17,25133,33,1.88 [1.28-2.76],0.001305382064391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TCN2,Transcobalamin-2,26012,36,3.81 [2.39-6.07],1.7696542505714254e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TEK,Angiopoietin-1 receptor,25832,34,5.41 [1.46-20.06],0.011603515787963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFAP2A,Transcription factor AP-2-alpha,21739,29,1.52 [1.02-2.26],0.0383301414837932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFF1,Trefoil factor 1,25610,35,2.51 [1.96-3.23],5.675668120581744e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFF2,Trefoil factor 2,25832,34,3.64 [2.59-5.12],1.0475806636859285e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFF3,Trefoil factor 3,25711,36,2.50 [1.92-3.27],1.494707630385293e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,25746,34,1.92 [1.44-2.55],8.409450128185966e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFA,Protransforming growth factor alpha,25705,33,2.17 [1.30-3.64],0.003189296625722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,25968,34,2.69 [1.42-5.07],0.0022658023889892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFBR1,TGF-beta receptor type-1,21822,29,2.90 [1.43-5.90],0.0031943070747575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFBR2,TGF-beta receptor type-2,25832,34,9.13 [5.98-13.95],1.4807774407417288e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,26057,36,7.05 [3.34-14.91],3.165783332704409e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THBS2,Thrombospondin-2,25740,35,3.25 [1.96-5.39],5.154713404804936e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THBS4,Thrombospondin-4,25738,36,4.48 [2.57-7.82],1.289066695665082e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,25446,36,5.32 [2.84-9.95],1.7747112098228833e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TIMP2,Metalloproteinase inhibitor 2,22457,29,1.91 [1.17-3.11],0.0091686896320064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,25740,35,3.03 [1.93-4.76],1.4237275253471626e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TINAGL1,Tubulointerstitial nephritis antigen-like,25652,35,5.14 [1.57-16.82],0.0068244106034857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMEM25,Transmembrane protein 25,22416,29,1.98 [1.34-2.92],0.0006087068232362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,22362,29,2.71 [1.78-4.12],3.068230339138417e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMPRSS15,Enteropeptidase,25620,34,1.94 [1.40-2.69],7.324776794204802e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMSB10,Thymosin beta-10,25740,35,1.64 [1.11-2.42],0.0121035426074476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNC,Tenascin,25829,36,2.82 [1.61-4.94],0.0002967641733491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNF,Tumor necrosis factor,25226,35,1.76 [1.23-2.53],0.0020434700478728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,25571,33,4.31 [3.02-6.17],1.0660425679032452e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,25571,33,1.88 [1.56-2.26],3.8565354418447015e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,26012,34,8.18 [5.39-12.42],5.836870988607845e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,25753,33,9.59 [5.05-18.22],5.03046286857282e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,25832,34,7.50 [4.39-12.82],1.691533323016282e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,25797,33,2.54 [1.55-4.16],0.000207144809505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,25239,34,2.03 [1.24-3.34],0.0051790692310424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,21977,28,4.39 [2.21-8.71],2.4174861184549453e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,25954,34,8.60 [5.44-13.60],3.436049058545409e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,25740,35,2.59 [2.03-3.31],2.7918941185591355e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,25968,34,5.27 [3.47-8.00],5.991062074400369e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,25571,33,2.57 [1.92-3.44],2.080803725499216e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,25967,35,3.13 [2.07-4.73],6.625323841910275e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,25571,33,3.81 [2.83-5.12],8.172239855068283e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,26013,36,3.14 [1.79-5.52],6.60808803326501e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFSF8,Tumor necrosis factor ligand superfamily member 8,22447,28,3.65 [1.92-6.92],7.646282866029727e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNNI3,"Troponin I, cardiac muscle",25270,35,1.50 [1.00-2.23],0.047763939894742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNR,Tenascin-R,25571,33,2.37 [1.20-4.65],0.0124236209562692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TP53I3,Quinone oxidoreductase PIG3,21504,27,2.31 [1.26-4.24],0.0069682075444877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TPP1,Tripeptidyl-peptidase 1,25579,33,1.89 [1.18-3.05],0.0087234484383625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TPR,Nucleoprotein TPR,21746,28,1.56 [1.06-2.29],0.0234147554146254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TPSAB1,Tryptase alpha/beta-1,25969,34,2.18 [1.21-3.93],0.0093391672788071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TREML2,Trem-like transcript 2 protein,25740,35,2.86 [1.39-5.88],0.0042863096259693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TSPAN1,Tetraspanin-1,25270,35,2.17 [1.35-3.51],0.0015177548517278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,25832,34,3.69 [1.53-8.93],0.0037755537083464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,25967,35,1.66 [1.11-2.50],0.0140053107427515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ULBP2,UL16-binding protein 2,25571,33,5.81 [3.49-9.66],1.1668750932468076e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UMOD,Uromodulin,25985,34,0.28 [0.19-0.42],1.339143353974846e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UNC5D,Netrin receptor UNC5D,21822,29,2.50 [1.08-5.81],0.0325967991214353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",USP28,Ubiquitin carboxyl-terminal hydrolase 28,22407,29,2.44 [1.64-3.62],1.0686898196918864e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VCAM1,Vascular cell adhesion protein 1,25784,36,7.09 [3.35-15.02],3.085774639479164e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VCAN,Versican core protein,25967,35,3.68 [1.48-9.13],0.0049618144853917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VEGFB,Vascular endothelial growth factor B,21822,29,8.61 [4.18-17.71],4.922367360919655e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VEGFD,Vascular endothelial growth factor D,25964,34,7.43 [3.30-16.71],1.2656463349718542e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VIT,Vitrin,22457,29,4.46 [2.64-7.54],2.2652561639820654e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VMO1,Vitelline membrane outer layer protein 1 homolog,25620,34,2.70 [1.70-4.28],2.3558431919689525e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VNN2,Vascular non-inflammatory molecule 2,25620,34,3.88 [1.78-8.48],0.0006764998858155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,21746,28,2.33 [1.14-4.76],0.0207509975670988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,22325,29,2.79 [1.89-4.11],2.2286528615761325e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,25705,34,6.17 [4.16-9.16],1.8642412484602584e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,25705,35,1.75 [1.18-2.59],0.0054226344122378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VWF,von Willebrand factor,26057,36,1.60 [1.08-2.38],0.0198591927532222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WAS,Wiskott-Aldrich syndrome protein,25239,34,0.54 [0.35-0.84],0.0056147668438145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WASL,Neural Wiskott-Aldrich syndrome protein,21822,29,1.46 [1.02-2.09],0.037723981524783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WFDC1,WAP four-disulfide core domain protein 1,21885,27,1.46 [1.05-2.03],0.0253766867209855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,25919,34,1.81 [1.21-2.71],0.0037823646896928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,24422,34,5.90 [3.99-8.73],5.506104276535637e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",25497,33,0.27 [0.14-0.51],7.949650346218469e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",25797,33,2.57 [1.12-5.87],0.0252662899233785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WNT9A,Protein Wnt-9a,25239,34,5.83 [3.64-9.36],2.601937469930852e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",XCL1,Lymphotactin,25954,34,1.80 [1.34-2.42],0.0001038524156591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",XPNPEP2,Xaa-Pro aminopeptidase 2,25832,34,0.69 [0.50-0.97],0.0309035292551695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,25270,35,2.19 [1.49-3.23],6.612139323092727e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ZCCHC8,Zinc finger CCHC domain-containing protein 8,21746,28,1.46 [1.02-2.09],0.0371727517501846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ZNF174,Zinc finger protein 174,21822,29,1.80 [1.12-2.88],0.0143360775606533
